Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

9 results about "Idebenone" patented technology

Idebenone (pronounced eye-deb-eh-known, trade names Catena, Raxone, Sovrima, among others) is a drug that was initially developed by Takeda Pharmaceutical Company for the treatment of Alzheimer's disease and other cognitive defects. This has been met with limited success. The Swiss company Santhera Pharmaceuticals has started to investigate it for the treatment of neuromuscular diseases. In 2010, early clinical trials for the treatment of Friedreich's ataxia and Duchenne muscular dystrophy have been completed. As of December 2013 the drug is not approved for these indications in North America or Europe. It is approved by the European Medicines Agency (EMA) for use in Leber's hereditary optic neuropathy (LHON) and was designated an orphan drug in 2007.

Oceanobacillus possesses idebenone-producing ability and high antioxidant capacity.

The present invention provides a bacterial strain that possesses higher free radical scavenging ability and idebenone production ability. [Solution] The Oceanobacillus Y-3 strain of the present invention was obtained by screening from black mud of Yuncheng Salt Lake in Shanxi Province. It possesses high free radical scavenging ability and strong iron ion reduction ability, exhibits high antioxidant activity, and has the ability to produce idebenone. The strain of the present invention has great potential for application in the fields of health foods and cosmetics.
Owner:JIANGNAN UNIV +1

Use of idebenone for the preparation of a medicament for the treatment of osteosarcoma

ActiveCN117159522BOrganic active ingredientsAntineoplastic agentsIdebenoneOsteosarcoma cell line
The application provides application of idebenone in preparation of a medicine for treating osteosarcoma. The application of idebenone or a pharmaceutically acceptable salt thereof in preparation of the medicine for treating osteosarcoma is achieved by carrying out proliferation experiments (CCK8 method) and invasion experiments (transwell invasion experiment) of osteosarcoma cell lines in vitro, quantitative analysis of cell viability in the CCK8 method proliferation experiment and quantitative analysis of the number of penetrated cells in the transwell invasion experiment; and constructing a nude mouse CDX (cell-derived xenograft) model, a PDX (human-derived xenograft) model and a tibial orthotopic / metastatic tumor model, intraperitoneally injecting idebenone, and quantitatively analyzing the tumor volume and tumor weight in the CDX model, the tumor volume and tumor weight in the PDX model and the tumor volume, the weight of the affected limb and the number of lung metastases in the tibial orthotopic / metastatic tumor model, which fully indicates that idebenone can inhibit the proliferation, invasion and metastasis of osteosarcoma.
Owner:NANFANG HOSPITAL OF SOUTHERN MEDICAL UNIV

Preparation process of idebene

PendingCN121554369AOrganic compound preparationQuinone preparation by oxidationPtru catalystIdebenone
According to the method, coenzyme Q0 and 10-bromocapraldehyde are taken as initial raw materials, selective alkylation reaction, catalytic hydrogenation reaction and oxidation reaction are carried out step by step, and specific catalyst combination and reaction condition control are adopted to obtain idebene. The method has the advantages that the catalyst is stable in activity, the yield and the purity of a target product are remarkably improved, and the method is simple in reaction step, environment-friendly and suitable for industrial production.
Owner:广州旭帆生物科技有限公司

Weight management composition

The invention provides a method of promoting weight management in a mammal comprising administering to the mammal a composition comprising at least one weight loss agent and at least one mitochondrial enhancer. The weight loss agent can be selected from the group consisting of psyllium, guar gum, capsaicin, chitosan, caffeine, gamboge, mume, capsaicin, yohimbine, butterfly pea, glucomannan, African mango, guarana, pyruvate, carnitine, beta-glucan, fucoxanthin, raspberry ketone, white kidney bean, kola nut, chromium, ginseng, psyllium, St. John's wort, dandelion, hydroxycitric acid, conjugated linoleic acid, green tea, black tea, coffee bean extract, forskolin, and bitter orange. The mitochondrial enhancer can be selected from the group consisting of beetroot extract, nitrate, idebenone, nicotinamide riboside, elamipretide, vitamin C, vitamin D, vitamin E, thiamine, riboflavin, magnesium, calcium, phosphate, phospholipid, creatine, pyruvate, coenzyme Q10, NADH, niacin, L-carnitine, dichloroacetate, curcumin, schisandrin, and resveratrol. Compositions for weight management are also provided.
Owner:ASERKIN CO LTD

Ectoine-containing anti-aging composition as well as preparation method and application thereof

The invention discloses an Ectoine-containing anti-aging composition and a preparation method and application thereof, and belongs to the technical field of cosmetics. Every 100 parts by weight of the Ectoine-containing anti-aging composition is prepared from the following raw materials in parts by weight: 10 to 30 parts of polyol, 2 to 4 parts of alkyl glycoside modified silicon dioxide, 3 to 10 parts of a skin conditioner, 2 to 6 parts of phospholipid, 2 to 5 parts of an oil phase, 2 to 4 parts of an emulsifier and the balance of deionized water, through the synergistic compatibility of the two active ingredients of Ectoine and idebenone, the composition has strong antioxidant ability, can effectively neutralize the oxidative stress of the environment and relieve oxidative damage, and further delays the photoaging process of the skin; the composition has an excellent anti-inflammatory effect and can effectively reduce inflammatory response; besides, through the innovative design of the nano carrier-alkyl glycoside modified silicon dioxide, the physical stability of the system is improved, the composition has excellent long-acting moisturizing capacity, meanwhile, the transdermal absorption and efficacy exertion of the active ingredients are enhanced, and the composition has wide application prospects in the field of external cosmetics.
Owner:SHANGHAI JAKA BIOTECH CO LTD

Bacillus marinus with the ability of producing idebenone and high antioxidant capacity

The application discloses a bacillus megaterium with the ability of producing aediron and high antioxidant capacity, and belongs to the field of microbial strains. The bacillus megaterium Y-3 is screened from black mud in a salt lake in Yuncheng, Shanxi, has high free radical scavenging capacity and strong iron ion reduction capacity, shows high antioxidant activity, and has the ability of producing aediron. The strain has great application potential in the fields of health products and cosmetics.
Owner:JIANGNAN UNIV +1

Compositions for improving cell viability, mitochondrial function and frataxin expression, and methods of use thereof

PCT designated stageWO2026060349A1Organic active ingredientsNervous disorderIdebenoneFrataxin
The present disclosure provides methods and compositions for improving cell viability, mitochondrial function and / or frataxin expression or treating Friedreich's ataxia (FRDA) comprising two or more of monomethyl fumarate (MMF) or a MMF prodrug such as dimethyl fumarate (DMF), nicotinamide (NAM), idebenone (IDB) and nitisinone (NTS).
Owner:MANTLE THERAPEUTICS INC +3

Composition for promoting hair growth or preventing hair loss

The present disclosure relates to a composition for promoting hair growth or preventing hair loss, and more particularly, the composition comprises idebenone, a salt thereof, a hydrate thereof, or a solvate thereof as an active ingredient, thereby being able to exhibit a hair follicle growth and / or hair (e.g., hair, eyebrows, eyelashes, etc.) growth effect, and ultimately being able to exhibit a hair growth promoting and / or hair loss preventing effect.
Owner:AMOREPACIFIC CORP

Idebenone-based bioactive nanomicelles, their preparation methods, and applications

This invention discloses a bioactive nanomicelle based on idebenone. By designing idebenone molecules with hydrophobic ends and functionalized hydrophilic polyethylene glycol, it exhibits excellent responsiveness, antioxidant properties, and cellular safety, making it suitable as a carrier for delivering drugs, genes, or other bioactive molecules for therapeutic and diagnostic applications. This invention also discloses a method for preparing this idebenone-based bioactive nanomicelle. The method for synthesizing the amphiphilic polymer of IDBP is simple, with mild reaction conditions, easy synthesis, convenient post-processing, high yield, and easy industrial production. The prepared amphiphilic polymer exhibits spontaneous assembly behavior in aqueous solution, forming a stable nanomicelle structure. This demonstrates the great potential of idebenone-based bioactive nanomicelles in drug delivery, potentially improving drug stability, bioavailability, and targeting.
Owner:HANZHONG VOCATIONAL & TECH COLLEGE